News
NSRX
3.405
+1.64%
0.055
Weekly Report: what happened at NSRX last week (0831-0904)?
Weekly Report · 4d ago
Nasus Pharma Sets October 8, 2026 Shareholder Meeting to Vote on Governance, Executive Pay and Option Pool
TipRanks · 09/04 20:28
Nasus Pharma files $50M ordinary shares offering
TipRanks · 09/01 20:55
Weekly Report: what happened at NSRX last week (0824-0828)?
Weekly Report · 08/31 09:20
Weekly Report: what happened at NSRX last week (0817-0821)?
Weekly Report · 08/24 09:21
Nasus Pharma Names Interim CFO as Longtime Finance Chief Resigns
TipRanks · 08/19 13:47
Nasus Pharma CFO Eyal Rubin to leave
Seeking Alpha · 08/19 11:05
Nasus Pharma Announces Transition of Chief Financial Officer
Barchart · 08/19 06:00
Nasus Pharma's H1 Loss Widens; Advances NS002 Toward Pivotal Study
NASDAQ · 08/17 15:09
Nasus Pharma 1H non-GAAP EPS of -$0.54
Seeking Alpha · 08/17 14:57
Nasus Pharma Boosts Cash and Equity in First-Half 2026 Filing
TipRanks · 08/17 13:22
Nasus Pharma H1 EPS $(0.54) Misses $(0.20) Estimate
Benzinga · 08/17 12:15
Weekly Report: what happened at NSRX last week (0810-0814)?
Weekly Report · 08/17 09:21
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
Barchart · 08/17 07:14
Weekly Report: what happened at NSRX last week (0803-0807)?
Weekly Report · 08/10 09:20
Weekly Report: what happened at NSRX last week (0727-0731)?
Weekly Report · 08/03 09:20
Nasus Pharma Installs Industry Veteran Brendan O’Grady as CEO to Steer Next Growth Phase
TipRanks · 07/28 12:57
Nasus Pharma appoints Brendan O’Grady as CEO
TipRanks · 07/28 11:35
Weekly Report: what happened at NSRX last week (0720-0724)?
Weekly Report · 07/27 09:21
Weekly Report: what happened at NSRX last week (0713-0717)?
Weekly Report · 07/20 09:20
More
Webull provides a variety of real-time NSRX stock news. You can receive the latest news about Nasus Pharma Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About NSRX
Nasus Pharma Ltd. is an Israel-based pharmaceutical company. The Company develops and manufactures pharmaceutical products and intranasal powder-based drug delivery systems. Its proprietary microsphere technology is designed to enable non-invasive intranasal administration of medications for emergency and acute-care applications, including the treatment of anaphylaxis and opioid overdose. The Company's formulations are designed to support rapid drug absorption and administration without the use of injections. Nasus Pharma Ltd. focuses on the development of drug delivery solutions intended for use by healthcare professionals, caregivers, first responders, and other non-professional users. The Company's products aim to improve the accessibility and administration of critical medications in emergency situations.